97 results
8-K
EX-99.1
rsen1241
20 Feb 24
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:05am
8-K
EX-99.1
z16c26
6 Nov 23
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
7:05am
8-K
EX-99.1
vp4 hxp0dnfxa
7 Aug 23
Axsome Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:02pm
424B5
l9l0 r9fs2wi
28 Jun 23
Prospectus supplement for primary offering
8:16pm
8-K
EX-1.1
3p5zsttlo wyajtq
28 Jun 23
Axsome Therapeutics Announces Proposed Public Offering of Common Stock
7:50pm
424B5
69z5ps7 inrhzt8q
27 Jun 23
Prospectus supplement for primary offering
8:51pm
8-K
EX-10.1
vckh qfia0r8
8 Jun 23
Departure of Directors or Certain Officers
5:02pm
S-3ASR
EX-4.7
a6ryf hueu
2 Dec 22
Automatic shelf registration
5:27pm